ReviewBiologics : targets & therapy2021

Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target.

Endeshaw Chekol Abebe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.